Markets

Merlin Shares Surge on C-130J Program Milestone

Merlin Inc shares surged up to 27.6% premarket after the U.S. Special Operations Command approved a key design review for its C-130J autonomy program, moving the contract closer to flight tests.

Daniel Marsh · · · 3 min read · 4 views
Merlin Shares Surge on C-130J Program Milestone

Shares of Merlin Inc (MRLN) experienced a significant surge in premarket trading on Friday following the announcement that its C-130J autonomy program with the U.S. Special Operations Command had passed a critical design review. The stock was trading at $9.14 at 6:47 a.m. EDT, representing a 25.7% gain, after peaking at a 27.6% increase earlier in the session.

Milestone for Defense Autonomy Program

Merlin, a recently public defense technology company focused on autonomous flight software, disclosed late Thursday that it had successfully completed the Critical Design Review (CDR) for its C-130J autonomy initiative. This engineering milestone validates the design architecture and allows the program to proceed toward integration, ground testing, and eventual flight demonstrations.

CEO and founder Matt George emphasized the significance of the achievement, stating that the CDR confirmation validates the company's approach to safe and scalable autonomy systems. The company now shifts its focus to integration and ground testing phases, with flight demonstrations as the next major objective.

Contract Structure and Financial Implications

The C-130J work is structured as an indefinite-delivery/indefinite-quantity (IDIQ) contract, which allows the government to place orders up to a predetermined ceiling without committing the full amount upfront. Merlin has indicated the IDIQ ceiling exceeds $100 million, providing a substantial potential revenue stream if all options are exercised.

Despite the positive news, analysts caution that the contract remains in its early stages. The company still faces significant hurdles including aircraft integration, rigorous testing, customer acceptance, and potential commercial certification. Forward-looking statements regarding test timing and performance carry inherent risks.

Market Context and Stock Performance

Merlin began trading on Nasdaq under the ticker MRLN on March 17 following a business combination. With limited trading history, the stock has exhibited considerable volatility, moving sharply on program milestones. The premarket surge reversed a year-to-date loss of 33% at Thursday's close, with after-hours trading showing a 22% gain to $8.79.

The broader market context was mixed, with Nasdaq and S&P 500 futures dipping ahead of U.S. payrolls data. Merlin's stock stood out as a notable gainer in an otherwise cautious trading environment.

Financial Position and Analyst Coverage

Merlin's latest balance sheet shows limited financial flexibility. The company reported first-quarter revenue of $1.0 million, a GAAP net loss of $90.4 million, and an adjusted EBITDA loss of $23.3 million. Following an equity financing on May 1, Merlin held $183 million in cash, cash equivalents, and short-term investments with no debt.

TD Cowen initiated coverage of Merlin this week with a buy rating and an $11 price target, citing the company's autonomy software for military aircraft including the C-130J and KC-135. The analyst community is beginning to track the post-listing story more closely.

Competitive Landscape

The defense autonomy sector remains competitive, with private companies like Shield AI, Skyryse, and Daedalean operating in similar spaces. Shield AI recently faced safety and operational complaints involving its V-BAT drone system, which the company rejected, attributing issues to user error. This highlights the challenges and scrutiny facing companies in this emerging field.

Friday's stock movement reflects investor optimism around the CDR milestone, but the key question remains whether this progress will translate into visible flight demonstrations and eventual revenue generation. The premarket surge may attract short-term traders, but sustained gains will depend on continued execution and contract expansion.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.